Why the study?
The study was designed to validate and subsequently design a risk scoring system based on the Lohman et al. risk calculator for patients undergoing brain or spinal tumor surgery.
Does a customized risk scoring system based on Lohman's calculator accurately predict 30-day postoperative adverse events (such as unplanned reoperation) in adult patients undergoing brain or spinal tumor surgery?
Does a customized risk scoring system based on Lohman's calculator accurately predict 30-day postoperative adverse events (such as unplanned reoperation) in adult patients undergoing brain or spinal tumor surgery?
Answers are grounded in this paper and cite their sources.
While direct replication of the Lohman risk calculator failed to correlate with postoperative adverse events in this neuro-oncological cohort, a customized Bayesian logistic regression model incorporating ECOG status, tumor recurrence, and ICU days demonstrated good utility for predicting 30-day unplanned reoperation.
This paper aims to validate and subsequently design a Risk Scoring System based on Lohman et al.(14) risk calculator for patients undergoing brain or spinal tumor surgery. Three models were tested: replication of Lohman's methodology, modification of risk groups, and development of a custom risk calculator. The replication of Lohman's instrument did not show significant correlations with adverse events in the study population. However, the adapted risk calculator demonstrated promising predictive performance for unplanned reoperation at 30 days, indicating good utility. The study suggests the potential applicability of the adapted risk calculator for predicting unplanned reoperation within 30 days for patients undergoing brain or spinal tumor surgery. Further research with larger samples and less missing data is recommended to confirm and enhance the utility of the proposed risk calculator. The results could be used to optimize decision-making and improve the quality of care for neuro-oncological surgery patients
No takes yet. Share an insight, caveat, or question.
Lagos et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: